Exacerbation of COVID 19 in Hypertensive Patients ( A review)
DOI:
https://doi.org/10.31351/vol30iss2pp23-30Keywords:
COVID-19, hypertension, Angiotensin Converting Enzyme 2 (ACE2)Abstract
Since its discovery in December 2019, corona virus was outbreak worldwide with very rapid rate, so it described by WHO as pandemic. It associated with severe acute respiratory distress syndrome, and can enter to cells through Angiotensin Converting Enzyme 2 (ACE 2) receptor which play an important role as regulator for blood pressure. Hypertension is a potential risk factor for sever acute respiratory syndrome COVID-19, and associated with high mortality rate as shown in many epidemiological studies. Moreover, specific antihypertensive medications that infected patients were receiving are not known; only data about renin-angiotensin-aldosterone system (RAAS) are available.
Received:21 /12/2020
Accepted:23 / 5/2021
How to Cite
1.
Naser NH, Abdul Aziz Alibeg A. Exacerbation of COVID 19 in Hypertensive Patients ( A review). Iraqi Journal of Pharmaceutical Sciences [Internet]. 2021 Dec. 9 [cited 2024 Nov. 19];30(2):23-30. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1286
